Drugdiscovery >> Drug Development >> News
4793
Views
GSK's diabetes Drug got an FDA 'okay' - drugdiscovery.com
GSK's diabetes Drug got an FDA 'okay' - drugdiscovery.com


Taneum, the diabetes drug of GSK has been given a green light by FDA. With this 'okay' sign the pharmaceutical company can enter new markets.
Read More >>


Tags: pharmatimes,pharma news, Eperzan, approved, albiglutide, Tanzeum, GSK, drug development, pain, diabetes, diabetes drug, new treatment for diabetes. - April 19, 2014
Related Articles
3250
Views
Scripps Florida Scientists has a new research towards a better diabetes drug Scripps Florida Scientists has a new research towards a better diabetes drug
The Scripps Research institute has a new foundings in the field of common diabetes drugs. Ths surprising research result are hoped to lead scientist towards a more effecite treatment for high blood su Read More >>

Tags: diabetes, diabetes drug, the scripps research institute, scripps diabetes, drug development, diabetic

2716
Views
Insights into diabetes treatment development Insights into diabetes treatment development
With more and more individuals suffering from diabetes every year, and growing treatment costs, the highest number of ongoing research projects among pharmaceutical and biotech companies is in the fi Read More >>

Tags: diabetes, treatment, drugs, research, focus, pharmaceutical, biotech, companies

3511
Views
Insulin in pills: no pain for diabetes patient Insulin in pills: no pain for diabetes patient
Diabetes is often treated by giving insulin injections. Scientist now work on packaging this fornmula into a pill - causing far less pain to the patients. Read More >>

Tags: capsule, insulin, diabetes

4411
Views
Entry of new Type 2 Diabestes drug in the UK: Only one per day Entry of new Type 2 Diabestes drug in the UK: Only one per day
The new drug, Lixisenatide, with the brand name Lyxumia is cheaper than existing drugs and it can be self administered daily once with an injection pen. It will work on GLP-1 hormone and control insu Read More >>

Tags: Type 2 Diabetes, Lyxumia, Lixisenatide

5922
Views
Glucose-lowering drugs might have effects on heart Glucose-lowering drugs might have effects on heart
One of the most common reason of being hospitalized because opf heart failure is diabetes - according to the data. Scientist say, the hear-risk effect of glucose lowering drugs are often overlooked on Read More >>

Tags: clinical trial, diabetes, gluvose-lowering drug, effect, heart, heart attack, heart failure

3694
Views
AstraZeneca's Bydureon Pen was approved by FDA AstraZeneca's Bydureon Pen was approved by FDA
Bydureon Pen means a once-weekly-treatment for adults with type 2 diabetes. Its producer, AstraZeneca announced that FDA has approved the treatment; however it shall not be used for type 1 diabetes or Read More >>

Tags: AstraZeneca, FDA, diabetes, ketoacidosis, Bydureon Pen

8376
Views
FDA asks for input on antibiotic drug discovery FDA asks for input on antibiotic drug discovery
A US Food and Drug Administration (FDA) taskforce working on advancing antibiotic drug development has outlined its initial areas of interest, and proposed a list of pathogens that could trigger exte Read More >>

Tags: antibiotic drug development, FDA, drug candidate

5385
Views
Electric controll of drug can prevent side-effects Electric controll of drug can prevent side-effects
Several drugs have side effects because they are active in those parts of the body where they should not be. A group of scientists created a "smart" implant, which might solve this problem. Read More >>

Tags: smart implant, scientists, side effects, drug development, electronic drug control

7577
Views
SOLIAIR™ - Breathing Made Easy! SOLIAIR™ - Breathing Made Easy!
SOLIAIR™ is a blend of botanical extracts and a food supplement that can help patients in chronic respiratory diseases such as Asthma, Bronchitis, COPD and other respiratory infections! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

5559
Views
Orphan drug designation for DengueCide Orphan drug designation for DengueCide
FDA has approved orphan drug designation to DengueCide, NanoViricides’ drug candidate for the treatment of dengue and dengue hemorrhagic fever. Read More >>

Tags: DengueCide, dengue, hemorrhagic fever, drug,orphan drug, NanoViricides

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013